R01CA45708/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1997	1
1998	1
1999	2
2003	1
2004	2
2005	3
2006	1
2008	3
2010	1
2011	1
2012	1
2013	3
2014	1
2025	0

1

EGFs and ERBBs--brief history and prospects.

Stern DF. Stern DF. Semin Cell Dev Biol. 2010 Dec;21(9):917-21. doi: 10.1016/j.semcdb.2010.10.006. Epub 2010 Oct 21. Semin Cell Dev Biol. 2010. PMID: 20970513 Free PMC article.

2

ErbBs in mammary development.

Stern DF. Stern DF. Exp Cell Res. 2003 Mar 10;284(1):89-98. doi: 10.1016/s0014-4827(02)00103-9. Exp Cell Res. 2003. PMID: 12648468 Review.

3

Phosphoproteomics for oncology discovery and treatment.

Stern DF. Stern DF. Expert Opin Ther Targets. 2005 Aug;9(4):851-60. doi: 10.1517/14728222.9.4.851. Expert Opin Ther Targets. 2005. PMID: 16083347 Review.

4

Genotype-selective combination therapies for melanoma identified by high-throughput drug screening.

Held MA, Langdon CG, Platt JT, Graham-Steed T, Liu Z, Chakraborty A, Bacchiocchi A, Koo A, Haskins JW, Bosenberg MW, Stern DF. Held MA, et al. Cancer Discov. 2013 Jan;3(1):52-67. doi: 10.1158/2159-8290.CD-12-0408. Epub 2012 Dec 13. Cancer Discov. 2013. PMID: 23239741 Free PMC article.

5

ErbB3 is required for ductal morphogenesis in the mouse mammary gland.

Jackson-Fisher AJ, Bellinger G, Breindel JL, Tavassoli FA, Booth CJ, Duong JK, Stern DF. Jackson-Fisher AJ, et al. Breast Cancer Res. 2008;10(6):R96. doi: 10.1186/bcr2198. Epub 2008 Nov 18. Breast Cancer Res. 2008. PMID: 19019207 Free PMC article.

6

Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method.

Bai Y, Cheng H, Bordeaux J, Neumeister V, Kumar S, Rimm DL, Stern DF. Bai Y, et al. PLoS One. 2013 Nov 21;8(11):e79901. doi: 10.1371/journal.pone.0079901. eCollection 2013. PLoS One. 2013. PMID: 24278211 Free PMC article.

7

Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway.

Colavito SA, Zou MR, Yan Q, Nguyen DX, Stern DF. Colavito SA, et al. Breast Cancer Res. 2014 Sep 25;16(5):444. doi: 10.1186/s13058-014-0444-4. Breast Cancer Res. 2014. PMID: 25252859 Free PMC article.

8

EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis.

Breindel JL, Haskins JW, Cowell EP, Zhao M, Nguyen DX, Stern DF. Breindel JL, et al. Cancer Res. 2013 Aug 15;73(16):5053-65. doi: 10.1158/0008-5472.CAN-12-3775. Epub 2013 Jun 21. Cancer Res. 2013. PMID: 23794705 Free PMC article.

9

Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer.

Modi S, DiGiovanna MP, Lu Z, Moskowitz C, Panageas KS, Van Poznak C, Hudis CA, Norton L, Tan L, Stern DF, Carter D, Seidman AD. Modi S, et al. Cancer Invest. 2005;23(6):483-7. doi: 10.1080/07357900500201301. Cancer Invest. 2005. PMID: 16203655

10

ErbB2 is required for ductal morphogenesis of the mammary gland.

Jackson-Fisher AJ, Bellinger G, Ramabhadran R, Morris JK, Lee KF, Stern DF. Jackson-Fisher AJ, et al. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17138-43. doi: 10.1073/pnas.0407057101. Epub 2004 Nov 29. Proc Natl Acad Sci U S A. 2004. PMID: 15569931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year